Abstract P346: Endothelial Function and NO Bioavailability are Improved in Angiotensin Ii-treated Transglutaminase-2 Knock-out Mice
We hypothesized that transglutaminase-2 (TG2) may contribute to the impaired functional properties of resistance arteries from angiotensin-II-treated mice. TG2-knockout mice (TG2-K/O, 12 weeks old, n=6) and wild type (WT) mice were treated or not with angiotensin-II (400ng/kg/min) for 14 days. Blood pressure (BP) and heart rate (HR) were measured by tail-cuff method. Endothelium-dependent and -independent relaxations were assessed by concentration-response curves to acetylcholine (1nM-to-100μM)±L-NAME (100μM) and sodium nitroprusside (10nM-to-1mM) respectively, in mesenteric arteries pre-contracted with norepinephrine (10μM). The expression of p-eNOS-(S1177)/eNOS, NOSIP (the negative modulator of eNOS), NOX-1, and its positive modulator ERp72 were evaluated in aorta by immunoblotting. Reactive oxygen species (ROS) production in aorta was evaluated by dihydroethidium staining. Plasma nitrate/nitrate were measured by ELISA. BP and HR were higher in TG2-K/O mice compared to WT (116.8±0.9 mmHg vs 89.6±1.5 mmHg, P<0.001; and 595.0±15.0 bpm vs 467.1±14.7 bpm, P<0.001, respectively). In both groups, angiotensin-II increased significantly BP (+28% in WT, and +21% in TG2-K/O) and HR (+33% in WT, and +9% in TG2-K/O). Acetylcholine-induced relaxation was preserved in WT and TG2-K/O and it was significantly impaired by angiotensin-II only in WT (-28%). L-NAME blunted this response in all the groups, although this effect was less evident in angiotensin-II-treated WT. Endothelium-independent relaxation was similar in all the groups. Plasma nitrates/nitrates and p-eNOS-(S1177)/eNOS were similar in WT and TG2-K/O, and they were reduced by angiotensin-II significantly only in WT (-37% and -44%, respectively). NOSIP expression was similar in both WT and TG2-K/O and was significantly increased by angiotensin-II only in WT (+40%). ROS production was similar in WT and TG2-K/O and significantly increased by angiotensin-II only in WT (+9%). NOX-1 and ERp72 were similar in WT and TG2-K/O and were significantly increased by angiotensin-II only in WT (+23% and +29%, respectively). In conclusion TG2 may contribute to endothelial dysfunction through the modulation of ROS production and the reduction of NO bioavailability in angiotensin-II infused mice.